Enantioselective UHPLC Screening Combined with


Journal

Analytical chemistry
ISSN: 1520-6882
Titre abrégé: Anal Chem
Pays: United States
ID NLM: 0370536

Informations de publication

Date de publication:
25 01 2022
Historique:
pubmed: 22 12 2021
medline: 15 3 2022
entrez: 21 12 2021
Statut: ppublish

Résumé

Enantioselective chromatography has been the preferred technique for the determination of enantiomeric excess across academia and industry. Although sequential multicolumn enantioselective supercritical fluid chromatography screenings are widespread, access to automated ultra-high-performance liquid chromatography (UHPLC) platforms using state-of-the-art small particle size chiral stationary phases (CSPs) is an underdeveloped area. Herein, we introduce a multicolumn UHPLC screening workflow capable of combining 14 columns (packed with sub-2 μm fully porous and sub-3 μm superficially porous particles) with nine mobile phase eluent choices. This automated setup operates under a vast selection of reversed-phase liquid chromatography, hydrophilic interaction liquid chromatography, polar-organic mode, and polar-ionic mode conditions with minimal manual intervention and high success rate. Examples of highly efficient enantioseparations are illustrated from the integration of chiral screening conditions and computer-assisted modeling. Furthermore, we describe the nuances of

Identifiants

pubmed: 34931812
doi: 10.1021/acs.analchem.1c04585
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1804-1812

Auteurs

Gioacchino Luca Losacco (GL)

Analytical Research and Development, MRL, Merck & Co., Inc., 126 E. Lincoln Avenue, Rahway, New Jersey 07065, United States.

Heather Wang (H)

Analytical Research and Development, MRL, Merck & Co., Inc., 126 E. Lincoln Avenue, Rahway, New Jersey 07065, United States.

Imad A Haidar Ahmad (IA)

Analytical Research and Development, MRL, Merck & Co., Inc., 126 E. Lincoln Avenue, Rahway, New Jersey 07065, United States.

Jimmy DaSilva (J)

Analytical Research and Development, MRL, Merck & Co., Inc., 126 E. Lincoln Avenue, Rahway, New Jersey 07065, United States.

Alexey A Makarov (AA)

Analytical Research and Development, MRL, Merck & Co., Inc., 126 E. Lincoln Avenue, Rahway, New Jersey 07065, United States.

Ian Mangion (I)

Analytical Research and Development, MRL, Merck & Co., Inc., 126 E. Lincoln Avenue, Rahway, New Jersey 07065, United States.

Francesco Gasparrini (F)

Department of Drug Chemistry and Technology, "Sapienza" University of Rome, P.le Aldo Moro 5, 00185 Rome, Italy.

Michael Lämmerhofer (M)

Institute of Pharmaceutical Sciences, Pharmaceutical (Bio-)Analysis, University of Tübingen, Auf der Morgenstelle 8, Tübingen 72076, Germany.

Daniel W Armstrong (DW)

Department of Chemistry, University of Texas at Arlington, Arlington, Texas 76019, United States.

Erik L Regalado (EL)

Analytical Research and Development, MRL, Merck & Co., Inc., 126 E. Lincoln Avenue, Rahway, New Jersey 07065, United States.

Articles similaires

Humans Meta-Analysis as Topic Sample Size Models, Statistical Computer Simulation
Humans Algorithms Software Artificial Intelligence Computer Simulation
Humans Robotic Surgical Procedures Clinical Competence Male Female
Risk Assessment Plant Leaves Isomerism Humans Stereoisomerism

Classifications MeSH